Herbalife Ltd (NYSE:HLF - Get Free Report) shares passed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $13.99 and traded as high as $15.06. Herbalife shares last traded at $14.3940, with a volume of 3,170,332 shares trading hands.
Key Headlines Impacting Herbalife
Here are the key news stories impacting Herbalife this week:
- Positive Sentiment: Third-quarter net sales rose 6% to $1.35 billion, beating analyst expectations, as product volume accelerated. Herbalife also raised its 2026 revenue outlook to $5.3 billion, above the roughly $5.2 billion consensus. Herbalife Q3 results
- Positive Sentiment: Management highlighted profitability, robust operating cash flow and debt reduction, which may improve financial flexibility. The company also pointed to ongoing demand for nutrition products amid healthy-living trends. Earnings call highlights
- Neutral Sentiment: Fourth-quarter revenue guidance of $1.3 billion was broadly in line with analyst expectations. Updated earnings guidance
- Negative Sentiment: The turnaround story faces execution risks: reports flagged the CEO’s departure and a softer margin outlook. EPS was $0.64—above some estimates but below the $0.73 Zacks consensus—leaving earnings performance less uniformly positive than the sales results. Q3 earnings, leadership and margin outlook
Analyst Upgrades and Downgrades
Several analysts recently commented on the stock. Citigroup reaffirmed a "buy" rating and set a $17.00 target price (down from $21.00) on shares of Herbalife in a report on Friday, August 7th. Weiss Ratings reiterated a "hold (c)" rating on shares of Herbalife in a research note on Thursday, October 22nd. Wall Street Zen cut shares of Herbalife from a "buy" rating to a "hold" rating in a report on Sunday. Zacks Research downgraded shares of Herbalife from a "strong-buy" rating to a "hold" rating in a research report on Thursday, October 29th. Finally, Texas Capital upgraded Herbalife to a "strong-buy" rating in a report on Thursday, September 17th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $17.67.
View Our Latest Analysis on Herbalife
Herbalife Price Performance
The firm has a market cap of $1.51 billion, a price-to-earnings ratio of 8.57, a P/E/G ratio of 0.44 and a beta of 0.74. The stock has a 50-day moving average of $12.77 and a 200-day moving average of $13.99.
Herbalife (NYSE:HLF - Get Free Report) last posted its quarterly earnings data on Monday, November 2nd. The company reported $0.64 EPS for the quarter, topping analysts' consensus estimates of $0.62 by $0.02. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.31 billion. Herbalife had a negative return on equity of 50.68% and a net margin of 3.41%. The company's revenue was up 3.9% on a year-over-year basis. During the same quarter last year, the company earned $0.50 EPS. On average, equities analysts expect that Herbalife Ltd will post 2.68 EPS for the current fiscal year.
Herbalife declared that its Board of Directors has approved a share buyback program on Tuesday, September 8th that authorizes the company to buy back $250 million in outstanding shares. This repurchase authorization authorizes the company to purchase up to 19.3% of its shares through open market purchases. Stock repurchase programs are generally a sign that the company's board of directors believes its stock is undervalued.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of HLF. Pacer Advisors Inc. bought a new stake in Herbalife during the first quarter worth $9,491,000. Bank of New York Mellon Corp acquired a new stake in shares of Herbalife in the 2nd quarter valued at $5,842,000. Dimensional Fund Advisors LP increased its stake in shares of Herbalife by 29.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,877,717 shares of the company's stock valued at $27,638,000 after purchasing an additional 425,968 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its stake in shares of Herbalife by 11.5% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,596,795 shares of the company's stock valued at $38,225,000 after purchasing an additional 267,539 shares during the last quarter. Finally, Corient Private Wealth LP raised its holdings in shares of Herbalife by 697.8% during the 2nd quarter. Corient Private Wealth LP now owns 179,125 shares of the company's stock worth $2,355,000 after buying an additional 156,672 shares in the last quarter.
About Herbalife
(
Get Free Report)
Herbalife Ltd. NYSE: HLF is a global nutrition and wellness company that develops and distributes products through a network of independent members and distributors. Its offerings include meal-replacement shakes, protein and other dietary supplements, vitamins, sports nutrition products, and personal-care items.
Founded in 1980 by Mark Hughes, Herbalife sells its products through direct-selling channels rather than primarily through traditional retail stores. Independent distributors market the products, provide product guidance, and may operate nutrition clubs or similar community-based businesses.
The company serves customers across numerous markets in North America, Latin America, Europe, Asia-Pacific, and other regions.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.